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Abstract 
 
Background: In Africa, neurodegenerative diseases in the elderly have become a major health concern due to the increase 
in live expectancy. Glutamate mediated neurotoxicity is involved in neurodegenerative diseases such as Ischemia, Epilepsy, 
Alzheimer’s and Parkinson diseases. Plants with antioxidant properties are reported to protect vital organs against 
glutamate toxicity. This study aims to assess the effect of Dichrocephala integrifolia against monosodium glutamate- 
mediated neurotoxicity and oxidative stress. 
Methodology: The decoction prepared from the leaves of Dichrocephala integrifolia was evaluated against monosodium 
glutamate-induced neurotoxicity in mice. The animals were grouped in seven groups of 6 animals each. The animals 
received daily; distilled water (p.o) for the distilled water and the negative control groups, one of the four doses of the 
decoction of the plant (35, 87.5, 175 or 350 mg/kg p.o) for the tests groups and memantine (20 mg/kg p.o) for the positive 
control group. Monosodium glutamate (2.5 g/kg ip) was injected daily to animals except those of the normal control group 
all the seven days of the experimentation. Animals were observed for aggressiveness, locomotor and forepaws muscle grip 
activities 30 min after monosodium injections. Brain reduced glutathione and malondialdehyde levels were also assessed 
following the behavioral tests on day 8. 
Results: The decoction of Dichrocephala integrifolia at the doses of 87.5 and 175 mg/kg significantly (p<0.01) inhibited 
the aggressiveness of monosodium treated mice, significantly (p<0.01) counteracted the reduction in locomotor and 
forepaws muscle grip capacity induced by monosodium glutamate. Furthermore, the decreases in reduced glutathione level 
and increases in lipid peroxidation level induced by monosodium glutamate were significantly (p<0.001) reversed by 
Dichrocephala integrifolia at the doses of 87.5 and 175 mg/kg. 
Conclusion: The results of this study reveal that Dichrocephala integrifolia is a medicinal plant that protects the brain 
against monosodium glutamate-mediated neurotoxicity. This can explain why this plant is intensively used in folk medicine 
in Cameroon to prevent and treat some central nervous system illnesses. 
 
Keywords: Neurotoxicity; Glutamate; Dichrocephala integrifolia; antioxidant 
 
Introduction 
 
The brain as the main vital organ of a living organism can suffer from injuries due to endogenous or exogenous 
substances, a phenomenon known as neurotoxicity. Neurotoxicity can result in diverse central nervous system diseases such 
as mood disorders and diverse psychiatric disturbances (Han et al., 2011; Mason et al., 2014). Epilepsy, hypoglycemia, 
ischemia, Alzheimer’s and Parkinson’s diseases are among the diseases where neurotoxicity generated by glutamate 
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dysregulation plays a central role (Ganesan et al., 2013, Rajagopal et al., 2013; Swamy et al., 2013). Glutamate is the 
primary excitatory neurotransmitter in the mammalian central nervous system. Despite this key role, glutamate may be 
toxic to neuron in case it is in excess (Shivasharan et al., 2013). In the brain, it binds to its receptors, which are N-methyl 
D-aspartate (NMDA), α –amino-3-hydroxyl-5-methyl-4-isoxaleprioprionic acid (AMPA), and Kainate receptors. 
Glutamate-mediated neurotoxicity can be mediated through all these above-mentioned receptors. Glutamate in the brain can 
also lead to the imbalance between prooxydant and antioxidant enzymes resulting in the production of reactive oxygen 
species and subsequent oxidative stress through an overstimulation of NMDA receptors or non-receptors pathway 
(Butterfield & Pocernich, 2003; Danysz & Parsons, 2012; Ganesan et al., 2013). Monosodium glutamate (MSG) or 
monosodium glutamate salt hydrate is a food additive used in the modern society gastronomy and which enhance food 
flavor, increase appetite and give a special food taste highly appreciated by its consumers (Neveen and Iman, 2010;  
Ganesan et al., 2013; Hassan et al., 2014). Despite the high consumption of MSG as a food additive, there are evidences 
suggesting the toxicity of oral or systemic administrations of MSG salt to rodents consecutively for 6 to 10 days from the 
dose- range of 0.5 g/kg to 3 g/kg (Ganesan et al., 2013, Hassan et al., 2014; Swamy et al., 2013; Shivasharan et al., 2013). 
In addition, MSG has been implicated in the mitochondrial oxidative status of different brain regions (Farombi & Onyema, 
2006, Shivasharan et al., 2013). Many medicinal plant extracts or their secondary metabolites have been reported to prevent 
MSG-induced-neurotoxicity in vivo and in vitro mainly due to their antioxydant capacities (Neveen and Iman, 2010; 
Ramanathan et al., 2007).  
Dichrocephala integrifolia is a plant of the family Asteraceae. It is used in folk medicine in central Africa in 
general and in Cameroon in particular to treat humans as well as livestock. Alone or in addition with other medicinal plants, 
different parts of D. integrifolia are used to treat malaria, asthma, worm infections, schizophrenia, epilepsy, dementia, 
headache and for tooth extraction. In fact, fresh leaves of D. integrifolia associated with those of Ageratum conyzoides are 
used in Tanzania in the treatment of eye infections while in central part of Cameroon, same fresh leaves are use for tooth 
exration (Moshi et al ., 2010; Agbor et al., 2011). Again, D. integrifolia is used by the population of west Cameroon to treat 
worm infections and amebiasis (Moudipa et al., 2005; Wabo et al., 2013).  
There are no sufficient studies on the pharmacological action of D. integrifolia on the central nervous system. 
Therefore, for a better validation of the uses of D. integrifolia in folk medicine to treat neurodegenerative diseases, we in 
this study, evaluated the effect of the decoction of leaves of D. integrifolia on MSG-induced neurotoxicity, alteration in 
behavior, reduction in locomotion and forepaws muscle grip capacities. The effect of the plant was also evaluated against 
MSG -induced oxidative stress. 
 
Materials and Methods 
Animals 
 
Wistar rats (180-200 g) and Swiss mice (25-30 g) of either sex obtained from the animal house of the Department 
of Zoology and Animal Physiology of the University of Buea were used in this study. All animals maintained on a 12 h 
light-dark cycle, were housed in standard cages in a number of 6 animals per cage with food and water available ad libitum. 
The experiments were carried in accordance with the International Guideline for the Care and Use of Laboratory Animal 
published by the United States National Institutes of Health (NIH publication No. 85-23, revised 1996) and the National 
Ethical Committee Guideline (N ̊FWA-IRB00001954). All efforts were made to minimize both the suffering and the 
number of animal used.  
 
Drugs and chemicals  
 
Monosodium glutamate salt (MSG) (Alfa Aesar, Germany), Memantine hydrochloride (MT) (Cayman Chemical, 
USA), Ellman reagent (Biochemica, China), Trichloroacetic acid and Thiobarbituric (Sigma Chemical, St Louis USA) were 
used in this study. 
 
Plant material and preparation of the decoction 
 
D. integrifolia’s fresh leaves were harvested in April 2014 in the locality of Buea (Cameroon), with coordinates: 
4̊15´30´´and 9̊25´48´´. The Botanical identification was done at the National Herbarium of Cameroon where a voucher 
specimen is conserved under the reference number: 24276/SRFcam. After collection, the leaves of the plant were carefully 
washed, shade dried and ground. The decoction of D. integrifolia was prepared daily according to the instructions of the 
herbalist. Ten (10) g of the leaves’ powder of D. integrifolia were introduced in 75 ml of distilled water and boiled for 20 
min. The decoction was then filtered using Whatman No1 filter paper and diluted 2; 4 and 10 time with distilled water. 
Twenty (20) ml of the filtrate was evaporated to dryness and the weight of the brown extract obtained was 700 mg. The 
yield of the extraction was 7%. The corresponding concentration of the stock solution was 35 mg/ml. The corresponding 
dose for the stock solution was 350 mg/kg and the different dilutions were 175; 87.5 and 35 mg/kg. The doses of D. 
integrifolia used in this study were determined based upon prescreening results (data not shown). 
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Phytochemical Screening 
 
The Phytochemical screening of the decoction of D. integrifolia was done using the following method: Foam test 
for saponins, Meyer’s test for alkaloids, Bornträger test for anthraquinones, Liebermann Buchard test for phytosterols and 
aqueous sodium hydroxide test for flavonoids (Trease and Evans, 2009). 
 
Glutamate mediated neurotoxicity 
Treatment schedule 
 
The mice were grouped in seven groups of 6 animals each as follow: Group I: distilled water (distilled water p.o); 
Group II: Negative control (distilled water p.o); Group III: Decoction (35 mg/kg p.o); Group IV: Decoction (87.5 mg/kg 
p.o); Group V: Decoction (175 mg/kg p.o); Group VI: Decoction (350 mg/kg p.o) and Group VII: Positive control 
(memantine 20 mg/kg p.o). Animals of each group received the various treatments one hour before the injection of MSG 
(2.5 g/kg ip). The injection of MSG was done to all of the groups except the distilled water which received an 
intraperitoneal administration of saline. The treatments were done continuously during seven days. The dose of MSG was 
chosen according to literature (Olney et al., 1972; Ramanathan et al., 2007; Ganesan et al., 2013) and prescreening 
experiment (data not shown), while that of memantine was done according to literature (Danysz & Parson, 2012). The 
animals were observed for locomotion and forelimbs grip capacity on days 1, 3, 5 and 7 of treatment and for any sign of 
aggressiveness all the seven days of treatment and 30 min after MSG injection. 
 
Behavioral tests 
Agressivity 
 
This test was used to evaluate the effect of D. integrifolia on MSG-induced agressivity and hyperactivity. Every 
day and 30 min after MSG administration, animals were observed for any sign of aggressiveness, hyperactivity and fighting 
or calmness. Mice were scored 5 when they exhibited aggressive and fighting behaviours and scored 0 for calmness 
(Neveen & Iman, 2010). 
 
Locomotion 
 
This test was used to evaluate the effect of D. integrifolia on MSG-induced alteration in locomotion using an open 
field apparatus. The open field was locally fabricated in ply wooden with the following dimensions 40 cm x 40 cm x 25 cm. 
The grid floor was further divided into 16 smaller squares of 10 cm x10 cm dimensions each. The locomotion or 
ambulatory behaviour of every single mouse was assessed every two days, 30 min after MSG administration by counting 
the number of lines crossed by the animal in five min time (Ngo Bum et al., 2012). 
 
String suspension test 
 
This test was performed as described by Barclay and coworkers in1981 with little modifications (Barclay et al., 
1981). This test was conducted every two days of treatment, immediately after the locomotor activity. And it was used to 
assess forelimbs grip capacity and strength of mice. For this purpose, each mouse individually were held by its tail and 
allowed to hang suspended with its fore arms, to a wire cable of 1 mm taut between two stands and 50 cm above a padded 
table. The time each animal remain suspended was recorded using a stopwatch for a period of 30 s. 
 
 
Biochemical evaluation 
Tissue preparation 
 
The tissue preparation was done on day 8. The animals individually were sacrificed by decapitation after light 
ether anesthesia and their skull were gently opened to quickly remove the brains. The brains were rinsed with saline and 
weighed then introduced in a mortar with the corresponding volume of 50 mM Tris-HCl, buffer to prepare 10% 
homogenate. The homogenates were centrifuged at 3000 rpm during 15 min and the supernatant were separated and used 
for the estimation of total protein, malondialdehyde level and reduced glutathione levels. 
 
Total protein concentration 
 
The method describes by Bradford in 1976 was used for the estimation of total protein content, while using the 
bovine serum albumin as standard. 
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Brain reduced gluthatione level 
 
The brain reduced glutathione (GSH) was assessed in the brain supernatant using Ellman’s reagent as described by 
Ellman in 1959. Twenty (20) μl of brain homogenates were mixed with 3 ml of Ellmant reagent in room temperature. After 
one hour, the absorbance of the yellow compound was read at 412 nm using a microplatte reader. The amount of 
glutathione was calculated with the formula of Beer Lambert using the extinction coefficient value of 13,600/M/cm. 
 
Brain Malondialdehyde level 
 
The brain Malondialdehyde (MDA) level was measured in the supernatant using the thiobabituric assay as 
described by Nelson et al (1994) with little modifications. To 1 ml of brain supernatant was added 0.5 ml of 
Thrichloroacetic acid (20%) and 1 ml of thiobarbituric acid (0.67%). The mixture was allowed to heat in a water bath at 
100C̊ for an hour. After cooling with tab water, the mixture was centrifuged at 3000 rpm for 15 min and the absorbance of 
the supernatant was read at 530 nm. The amount of MDA was calculated with the formula of Beer Lambert using the 
extinction coefficient value of 1.56x105M/cm (Fotio et al., 2009). 
 
Acute toxicity 
 
The acute toxicity of D. integrifolia was determined in Wistar rats according to the protocol of the Organization 
for Economic Corporation and Development (OECD) and principle of good laboratory Practice (OECD, 2001). Four (4) 
groups of 6 rats each (3 males and 3 females) received the following doses of the plant extract in a single oral 
administration: 0; 2000; 3000 and 5000 mg/kg. Prior to the administration animals were subjected to fasting. The general 
behavior (locomotion, sensitivity to noise, sensitivity to touch, aspect of their stools, feeding behavior, phonation etc) of the 
rats was observed for 2 hours after treatment. 3 hours after administration of the decoction, the rats were given food and 
water ad libitum. During one week, the rats were observed 2 hours per day for any sign of toxicity such as asthenia, 
piloerection, salivation or dead. 
 
Statistical analysis 
 
Graphpad Instat software 3.10 for windows was used for the statistical analysis. Results are expressed as Mean ± 
SEM. One-way analysis of variance (ANOVA) was used to analyze the differences among groups. ANOVA was followed 
by Turkey for multiple comparisons group and Dunnet when needed. The values of p<0.05 were considered to be 
significant. 
 
Results 
Results of phytochemical screening  
 
The decoction of D. integrifolia contains alkaloids, saponins, tannins, flavonoids, anthraquinones and triterpenes (Table 1). 
 
Table 1: Phytochemical components of the decoction of the leaves of D. integrifolia  
 
 
 
 
 
 
 
 
 
 
+ = Trace; ++ = Moderate; +++ = Abundance 
 
Effects of D. integrifolia on the agressivity of glutamate treated-mice  
 
The animals which received distilled water exhibited normal behaviour and they were not aggressive. The animal 
of the negative control exhibited fighting from day 4 upward. The score of aggressiveness was highest on days six and 
seven of treatment in negative control group. The plant decoction at the dosage of 87.5 mg/kg significantly (p<0.05) 
reduced the aggressiveness of mice (Table 2). 
 
 
Constituent Inference 
Alcaloïds ++ 
Flavonoïds +++ 
Tannins +++ 
Triterpenes ++ 
Anthraquinones + 
Saponins +++ 
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Table 2: Effects of D. integrifolia on the agressivity of monosodium glutamate-treated mice 
Results are mean ± SEM, n= 6 mice. *p<0.05 or **p<0.01, vs negative control. Data were analyzed by one-way ANOVA 
followed by Tukey-kramer multiple comparisons group. DW= Distilled Water; MSG=Monosodium glutamate, DI= 
Dichrocephala integrifolia, MT= Memantine (20 mg/kg per os). 
 
Effects of D. integrifolia on locomotor activity of monosodium glutamate-treated mice. 
 
There were no significant changes in the locomotion of the animals of the distilled water group during the seven 
days of treatment. Administration of MSG resulted in significant decreased in animal locomotion in negative control 
starting from the third day of administration when compared to distilled water ([F (6, 35) = 6.629; P<0.0001]). The 
percentage of reduction of locomotion in MSG-treated mice from day 1 to day 7 is 61%.  Pretreatment of animal with D. 
integrifolia (87.5 and 175 mg/kg) significantly improved locomotor activity when compared to negative control [F (6, 35) = 
17.440; P<0.0001] (figure 1). MT also counteracted the reduction in locomotion induced by MSG (figure 1). 
 
Figure 1: Effects of D. integrifolia on locomotor activity of monosodium glutamate treated-mice. 
Results are mean ± SEM, n= 6 mice. *p<0.05, **p<0.01, ***p<0.001 vs negative control. Data were analyzed by one-way 
ANOVA follow by Tukey-kramer multiple comparisons group. DW= Distilled Water, PC= positive control (Memantine 20 
mg/kg per os), NC=Negative control, 35; 87.5; 175 and 350= doses of Dichrocephala integrifolia. 
 
Effects of D. integrifolia on forepaws muscle grip capacity of monosodium glutamate-treated mice. 
 
There were no significant changes in forepaws muscle grip capacity of the animals of the distilled water group 
during the seven days of the treatment. On the other hand, seven days administration of MSG in animals led to a significant 
reduction of the time of suspension of the animal of negative control on a string taut from day 3 upward when compared to 
distilled water. D. integrifolia (87.5 mg/kg) significantly increased the time the animal remained suspended on the string on 
day seven when compared to negative control [F (6, 35) = 9.368; P<0.0001]. There were no changes in forepaws muscle 
grip capacity of MT group when compared to distilled water. 
 
 
 
 
Treatment 
Doses  
(mg/kg + g/kg) Score day 4 Score day 5 Score day 6 Score day 7 
DW + NaCl -- + -- 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00** 0.00 ± 0.00** 
DW + MSG -- + 2.5 2.50 ± 1.05 3.33 ± 1.05 4.16 ± 0.83 4.16 ± 0.83 
DI + MSG 35 + 2.5 1.67 ± 1.05 1.67 ± 1.05 2.50 ± 1.05 3.33 ± 1.05 
DI + MSG 87.5 + 2.5 0.00 ± 0.00 0.00 ± 0.00 0.83 ± 0.83* 0.83 ± 0.83* 
DI + MSG 175 + 2.5 0.00 ± 0.00 0.83 ± 0.83 1.67 ± 1.05 1.67 ± 1.05 
DI + MSG 350 + 2.5 0.00 ± 0.00 1.67 ± 1.05 1.67 ± 1.05 2.50 ± 1.05 
MT + MSG 20 + 2.5 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00** 0.00 ± 0.00** 
** *** ** 
*** *** 
*** 
* 
*** 
* 
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                 Figure 2: Effects of D. integrifolia on muscle grip capacity of monosodium glutamate-treated mice. 
Results are mean ± SEM, n= 6 mice. *p<0.05, **p<0.01, ***p<0.001 vs monosodium glutamate alone treated mice. Data 
were analyzed by one-way ANOVA plus Tukey-kramer multiple comparisons group. DW= Distilled Water, PC= positive 
control (Memantine 20 mg/kg per os), NC=Negative control, 35; 87.5; 175 and 350= doses of Dichrocephala integrifolia. 
 
Effects of D. integrifolia on brain reduced glutathione level of monosodium glutamate-treated mice 
 
Figure 3 shows the brain level of reduced glutathione (GSH) of the MSG-treated mice. Whereas a significant 
decrease in brain glutathione level was observed with negative control, treatment with D. integrifolia (87.5 and 175 mg/kg) 
and standard drug MT as positive control significantly reversed the decrease of GSH level in the brain [F (6, 35) = 24.982; 
P<0.0001] (figure 3). 
 
 
Figure 3: Effects of D integrifolia on brain reduced glutathione level of monosodium glutamate treated mice 
Values are mean ± SEM, n= 6 mice. *p<0.05, **p<0.01, ***p<0.001 vs monosodium glutamate alone treated mice. Data 
were analyzed by one-way ANOVA plus Tukey-kramer multiple comparisons group. DW= Distilled Water, PC= positive 
control (Memantine 20 mg/kg per os), NC=Negative control. 
 
Effects of D. integrifolia on malondialdehyde level of monosodium glutamate treated mice 
 
Seven days of administration of MSG in mice resulted to an increase in brain MDA level in the negative control 
when compared to distilled water. The co administration of D. integrifolia (87.5; 175 and 350 mg/kg) and MSG (2.5 g/kg) 
reduced the level of brain MDA when compared to negative control ([F (6, 35) = 128.71; P<0.0001]) (Figure 4). MT (20 
mg/kg) also reduced the level of MDA when compare to negative control (Figure 4). 
 
 
** ** ** *
* 
*** *** 
* * 
*** 
*** 
** 
*** 
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Figure 4: Effects of D. integrifolia on Malondialdehyde level of monosodium glutamate treated mice. 
Values are mean ± SEM, n= 6 mice. *p<0.05, **p<0.01, ***p<0.001 vs negative control. Data were analyzed by one-way 
ANOVA plus Tukey-kramer multiple comparisons group. DW= Distilled Water, PC= positive control (Memantine 20 
mg/kg per os), NC=Negative control, 35; 87.5; 175 and 350: doses of Dichrocephala integrifolia. 
 
Results of acute toxicity study 
 
There were no signs of toxicity or dead at de dose of up to 3000 mg/kg after a single administration of D. 
integrifolia. Nevertheless, at the maximum dose of 5000 mg/kg some adverse effects were recorded such as hyperactivity, 
asthenia and piloerection (Table 3). 
 
Table 3: Acute toxicity of the decoction D. integrifolia 
M/T=Mortality over the Total number of treated rats; Absent = No sign of toxicity observed during the experimentation 
period (7 days). The rats in control group received distilled water (10 ml/kg) while the others received the decoction of D. 
integrifolia as a single oral administration at the following doses: 2000, 3000 and 5000 mg/kg. 
 
Discussion 
 
Glutamate is the most abundant excitatory neurotransmitter in the central nervous system where it is involved in 
70 % of excitatory neurotransmission (Cekic et al., 2005; Danysz & Parsons, 2012). Oral or intraperitoneal administrations 
of MSG have widely been used as an animal model to evaluate the beneficial effects of medicinal plants against glutamate-
induced neurotoxicity and oxidative stress (Ganesan et al., 2013). In this study, we evaluated the effect of the decoction of 
D. integrifolia, a medicinal herb used by indigenous population in Cameroon to treat central nervous system disorders, 
against MSG-induced neurotoxicity and oxidative stress in mice. Seven days intraperitoneal injections of MSG in mice at 
the dosage of 2.5 g/kg resulted in toxic effect evidenced by the aggressiveness, fighting behavior, reduction in locomotion 
and muscle grip strength activities in the animals of the negative control group. Pretreatment of animals with oral 
administration of the decoction of the plant at the doses of 87.5; 175 and 350 significantly prevented these toxic effects of 
MSG. Oral administration of D. integrifolia before the administration of MSG reduces the aggressiveness of mice, inhibited 
Treatment Doses (mg/kg) Sex M/T  Toxic symptoms 
Distilled water 
 −− 
Male 0/3 Absent 
Femelle 0/3 Absent 
D. integrifolia 
 
2000 
 
Male 0/3 Absent 
Femelle 0/3 Absent 
D. integrifolia 
 
3000 
 
Male 0/3 Absent 
Femelle 0/3 Absent 
D. integrifolia 
 
5000 Male  0/3 Hypoactivity, asthenia, piloerection 
Femelle 0/3 Hypoactivity, asthenia, piloerection 
*** 
*** 
** 
*** 
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the fighting behavior and restored the locomotion and the forepaws muscle grip capacities. These results showed that D. 
integrifolia has neuroprotective effect against MSG-induced neurotoxicity. This neuroprotection of the plant against MSG 
neurotoxicity was comparable to that of MT a standard drug used in the treatment of Alzheimer disease and which has 
beneficial effects against other neurodegenerative diseases (Danysz & Parson, 2012). The mechanism of action to explain 
neuroprotective action of MT is atypical and involves the blockage of the NMDA receptor channel without a total 
inactivation of the neurotransmission (Wenk et al., 2006; Danysz & Parson, 2012).  
Apart from behavioral changes, one-week intaperitoneal administration of MSG glutamate in mice resulted in 
brain oxidative stress evidenced by the results of the dosage of reduced gluthation and malondialdehyde level. In fact, the 
brain level of GSH was reduced in the brain of animals of the negative control while the amount of malondialdehyde was 
elevated in the negative control when compared to those of animal in the distilled water group. Our results are similar with 
earlier works, which found that MSG administration in rodents could lead to the reduction of antioxidant enzymes such as 
glutathione and consequent accumulation of reactive oxygen species and neurodegeneration (Ramanathan et al., 2007, 
Rajagopal et al., 2013). The pretreatment of animal with the decoction of D. integrifolia at the doses of 87.5 and 175 mg/kg 
significantly inhibited the MSG induced oxidative stress. This is visible through the elevated amount of GSH in the brain; 
and the reduced level of MDA level is a marker of brain lipid peroxidation level. The effect of D. integrifolia was 
comparable to that of MT (20 mg/kg p.o). These findings are in line with literature, which reported that MT could prevent 
neurons against oxidative stress induced by MSG. In fact, in case of overstimulation of NMDA by glutamate, MT blocks 
the receptor channel. This prevents calcium influx to the postsynaptic receptor and subsequent exitotoxicity and oxidative 
stress (Danysz & Parson, 2012, Rajagopal et al., 2013). The results of the phytochemical analysis of D. integrifolia revealed 
the presence in the decoction of the plant of some metabolites such as flavonoids, tannins and anthraquinones. Therefore, it 
can be hypothesized that the beneficial effects of D. integrifolia against MSG-mediated neurotoxicity in mice could be 
explainrd by its antioxidant properties since these types of secondary metabolites are known to have good antioxydant 
capacities and have also been reported to be beneficial in neurodegenerative diseases (Nehlig, 2012; Swamy, et al., 2013).  
The results of the acute toxicity of the decoction of D. integrifolia showed that the lethal dose 50 of the plant is higher than 
5000 mg/kg thus D. integrifolia is safe for human consumption (OECD, 2011). 
 
Conclusion 
 
At the end of this study, we can conclude that the decoction of D. integrifolia counteracts MSG-induced hyper 
excitation, alteration in behavior and oxidative stress. These results can at least explain the wide use of this herb in 
traditional medicine in the treatment of central nervous disorders. Nevertheless, to understand the exact mechanism by 
which this plant exerts neuroprotection, other specific animal models of central nervous system disease are needed. 
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